Formosa Laboratories' Acquisition of Synchem Signals CDMO Growth in North America
Formosa Laboratories Acquires Synchem: A Strategic Move
Formosa Laboratories has finalized the acquisition of Synchem, a significant development in the Contract Development and Manufacturing Organization (CDMO) sector. This move underlines Formosa Laboratories' dedication to expanding its footprint in North America and meeting the needs of pharmaceutical customers.
Enhancing Industry Presence and Capabilities
The acquisition of Synchem is set to enhance Formosa Laboratories' presence and capabilities in the North American CDMO market, positioning the company for future growth and success. By integrating Synchem's resources and expertise, Formosa Laboratories aims to provide enhanced services to its clients.
Commitment to Pharmaceutical Sector
Formosa Laboratories' acquisition of Synchem underscores its commitment to the pharmaceutical sector and signifies a strategic move to better serve the industry's evolving requirements. With a focus on expansion and innovation, Formosa Laboratories is poised to deliver comprehensive CDMO solutions to its growing client base.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.